UBS Group’s Allena Pharmaceuticals, Inc. Common Stock ALNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-83,827
| Closed | -$16K | – | 10413 |
|
|
2022
Q2 | $16K | Buy |
83,827
+69,893
| +502% | +$13.3K | ﹤0.01% | 6226 |
|
|
2022
Q1 | $4K | Sell |
13,934
-46,065
| -77% | -$13.2K | ﹤0.01% | 8344 |
|
|
2021
Q4 | $35K | Buy |
59,999
+22,313
| +59% | +$13K | ﹤0.01% | 6141 |
|
|
2021
Q3 | $34K | Buy |
37,686
+35,186
| +1,407% | +$31.7K | ﹤0.01% | 5536 |
|
|
2021
Q2 | $3K | Sell |
2,500
-7,274
| -74% | -$8.73K | ﹤0.01% | 7783 |
|
|
2021
Q1 | $13K | Buy |
+9,774
| New | +$13K | ﹤0.01% | 6743 |
|
|
2020
Q2 | – | Sell |
-7,757
| Closed | -$7K | – | 7452 |
|
|
2020
Q1 | $7K | Buy |
+7,757
| New | +$7K | ﹤0.01% | 6267 |
|
|
2019
Q4 | – | Sell |
-3,258
| Closed | -$13K | – | 7298 |
|
|
2019
Q3 | $13K | Buy |
3,258
+3,231
| +11,967% | +$12.9K | ﹤0.01% | 6055 |
|
|
2019
Q2 | $0 | Buy |
+27
| New | – | ﹤0.01% | 7251 |
|
|
2019
Q1 | – | Sell |
-5,488
| Closed | -$30K | – | 7256 |
|
|
2018
Q4 | $30K | Buy |
5,488
+2,708
| +97% | +$14.8K | ﹤0.01% | 5581 |
|
|
2018
Q3 | $30K | Sell |
2,780
-865
| -24% | -$9.34K | ﹤0.01% | 5647 |
|
|
2018
Q2 | $47K | Buy |
+3,645
| New | +$47K | ﹤0.01% | 5121 |
|
|
2018
Q1 | – | Sell |
-1,974
| Closed | -$20K | – | 7151 |
|
|
2017
Q4 | $20K | Buy |
+1,974
| New | +$20K | ﹤0.01% | 5603 |
|